RWC UNPLUGGED* │ 7:30 am – 12:00 pm

8:00 am – 12:00 pm
This half-day program will provide data-driven, unfiltered and “raw” discussions about drugs and devices that may impact retina. Join conversations with industry experts and clinical experts on the most debated topics in all of retina. Every RWC attendee is welcome to participate at no additional cost, but we do ask that you pre-register so we can prepare accordingly (use the online meeting registration form to reserve your seat).
*This portion of Retina World Congress 2019 is not approved for AMA PRA Category 1 Credit(s)™.
»  VIEW RWC UNPLUGGED AGENDA

Official Start of the Meeting

View PDF Version (updated as of Mar 13)

INDUSTRY EXPERT THEATER LUNCH** │ 12:00 pm – 1:00 pm

12:00 pm – 1:00 pm
Fluid and Retina: Where Do We Draw the Line? A Presentation of Different Perspectives
Sponsored by Novartis **This portion of the meeting is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina World Congress 2019 or its accredited provider.

GENERAL SESSIONS │ 1:00 pm – 5:30 pm

Welcome

1:00 pm – 1:15 pm
Welcome
Rishi P. Singh, MD

Ocular Oncology

Session Chairs: Rubens N. Belfort, MD, PhD; J. William Harbour, MD
1:15 pm – 1:18 pm
Pretest
Rubens N. Belfort, MD, PhD
1:18 pm – 1:25 pm
Management of High-risk Choroidal Melanoma
Carol L. Shields, MD
1:25 pm – 1:32 pm
Invisible Tumors or Giant Iris Melanocyte
Jerry A. Shields, MD
1:32 pm – 1:39 pm
Using Imaging to Help Diagnose Ocular Tumors
Rubens N. Belfort, MD, PhD
1:39 pm – 1:46 pm
Anti-VEGF Therapy for Radiation Retinopathy
Prithvi Mruthyunjaya, MD, MHS
1:46 pm – 1:53 pm
Choroidal Nevus Risk Factors: Weighted Relevance Based on Molecular Prognostication
J. William Harbour, MD
1:53 pm – 2:00 pm
The Expanding Use of Ophthalmic Artery Chemosurgery
Timothy G. Murray, MD, MBA, FACS
2:00 pm – 2:07 pm
Future Therapeutics for Ocular Oncology
Arun D. Singh, MD
2:07 pm – 2:10 pm
Posttest
Arun D. Singh, MD
2:10 pm – 2:30 pm
Panel Discussion: Surgical and Medical Management of Ocular Oncology Case
Moderator: Arun D. Singh, MD
Panelists: Prithvi Mruthyunjaya, MD, MHS; Timothy G. Murray, MD, MBA, FACS; Eduardo B. Rodrigues, MD; Carol L. Shields, MD; Jerry A. Shields, MD

Macular Surgery

Session Chairs: André V. Gomes, MD, PhD; Tarek S. Hassan, MD; Virgilio Morales-Canton, MD
2:35 pm – 2:38 pm
Pretest
Tarek S. Hassan, MD
2:38 pm – 2:45 pm
Ectopic Inner Foveal Layers in ERMs, Surgical Results
Andrea Govetto, MD, PhD
2:45 pm – 2:52 pm
Submacular Irrigation for Large Macular Holes
Mario J. Saravia, MD, PhD
2:52 pm – 2:59 pm
Development of a Deep Learning System for Digitally Enhanced Internal Limiting Membrane Peeling
Kazuaki Kadonosono, MD, PhD
2:59 pm – 3:06 pm
Approach to Lamellar Macular Hole Repair
Yuki Morizane, MD, PhD
3:06 pm – 3:13 pm
Inverted ILM Flap Techniques and Indications
Jerzy Nawrocki, MD, PhD
3:13 pm – 3:20 pm
Observational Management of Idiopathic ERMs in Patients with Good Initial VA: One Year Follow-up
Harry W. Flynn Jr., MD
3:20 pm – 3:27 pm
Autologous Tissue Transplantation for Macular Holes
Tamer H. Mahmoud, MD, PhD
3:27 pm – 3:34 pm
Surgical Management of AMD in Anti-VEGF Era
Cesare Mariotti, MD
3:34 pm – 3:41 pm
Optic Pits
Leandro C. Zacharias, MD, PhD
3:41 pm – 3:48 pm
Managing Myopic Foveoschisis: Surgery or Observation
Yusuke Oshima, MD, PhD

Abstract Winners

3:48 pm – 3:51 pm
Comparison of Clinical Outcomes Between ‘Heads-up’ 3D Viewing System and Conventional Microscope in Macular Hole Surgeries
Nasiq Hasan, MD
3:51 pm – 3:54 pm
Disorganization of Retinal Inner Layers as a Biomarker for Idiopathic Epiretinal Membrane After Macular Surgery: The DREAM Study
Dinah Zur, MD
3:54 pm – 3:57 pm
Autologous Transplantation of the Internal Limiting Membrane Flaps for Myopic Macular Hole
Ashraf Shaarawy, MD
3:57 pm – 4:20 pm
Panel Discussion: Macular Surgery
Moderator: Gaurav K. Shah, MD
Panelists: Ernesto Bali, MD; Francesco Boscia, MD; Niels Crama, MD, FEBO; Francesco Faraldi, MD; Faisal Fayyad, MD; Nelson A. Sabrosa, MD, PhD; Mahmoud M. Soliman, MD

Medical Retina: Retinal Vein Occlusion

Session Chairs: Arturo Alezzandrini, MD, PhD; Baruch D. Kuppermann, MD, PhD; Jorge C. P. Rocha, MD, PhD
4:25 pm – 4:28 pm
Pretest
Arturo Alezzandrini, MD, PhD
4:28 pm – 4:35 pm
Effect of Anti-VEGF and Steroids Treatment on Retinal Non-perfusion
Jorge C.P. Rocha, MD, PhD
4:35 pm – 4:42 pm
SCORE-2 Results and Implications to Clinical Practice
Michael S. Ip, MD
4:42 pm – 4:49 pm
Addressing RVO with Corticosteroids
Baruch D. Kuppermann, MD, PhD

Abstract Winners

4:49 pm – 4:52 pm
Intravitreal Anti-VEGF Injections Followed by Transitory Central Retinal Artery Occlusion; Specific Points Analyzing a Rare Adverse Event: A Case Series Study
Nadyr A. Damasceno, MD, PhD
4:52 pm – 4:55 pm
Use of Optical Coherence Tomography Angiography Capillary Perfusion Density Measurements to Detect and Grade Macular Ischemia
Amy Babiuch, MD
4:55 pm – 4:58 pm
Effect of Funding Source on Reporting Bias in Studies of Intravitreal Anti-vascular Endothelial Growth Factor Therapy for Retinal Vein Occlusion
Michael Venincasa, MD
4:58 pm – 5:01 pm
Increased Inner Retinal Layer Reflectivity in Eyes with Acute CRVO Correlates with Worse Visual Outcomes at 12 Months
Yasha Modi, MD

Panel Discussion

5:06 pm – 5:30 pm
Medical Retina: Retinal Vein Occlusion
Moderator: Marcio B. Nehemy, MD, PhD
Panelists: Joaquin Bafalluy, MD; Andres Bastien, MD; Magno A. Ferreira, MD, MsC, MBA, PhD; Sharon Fekrat, MD, FACS; Francisco J. Rodriguez, MD; Marcelo Zas, MD, PhD

WELCOME RECEPTION* │ 6:00 pm – 7:30 pm

6:00 pm – 7:30 pm
Join us the first night of the meeting as we welcome more than 1,000 faculty and attendees to Retina World Congress 2019. Take this opportunity to network one-on-one with colleagues while everyone enjoys light appetizers and drinks.
*This portion of the meeting is not approved for AMA PRA Category 1 Credit(s)™.